A

Atrys Health SA
MAD:ATRY

Watchlist Manager
Atrys Health SA
MAD:ATRY
Watchlist
Price: 2.66 EUR -0.75% Market Closed
Market Cap: 202.2m EUR
Section:
 

Relative Value

The Relative Value of one ATRY stock under the Base Case scenario is 5.31 EUR. Compared to the current market price of 2.66 EUR, Atrys Health SA is Undervalued by 50%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ATRY Relative Value
Base Case
5.31 EUR
Undervaluation 50%
Relative Value
Price
A
Worst Case
Base Case
Best Case

Valuation Multiples

0.9
P/S
P/S
Price to Sales
0.9
vs History
96
vs Industry
59
Median 3Y
1.3
Median 5Y
2.2
Industry
2.3
Forward
0.9
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-8.1
Median 5Y
-15.7
Industry
22.4
Forward
100.1
More Details
8.7
P/OCF
P/OCF
Price to OCF
8.7
vs History
49
vs Industry
Median 3Y
-23.6
Median 5Y
8.8
Industry
14.4
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-7.9
Median 5Y
-6.4
Industry
21.5
More Details
0.8
P/B
P/B
Price to Book Value
0.8
vs History
90
vs Industry
66
Median 3Y
1
Median 5Y
1.1
Industry
2.2
More Details
1.7
EV/S
EV/S
Enterprise Value to Sales
1.7
vs History
96
vs Industry
46
Median 3Y
2.1
Median 5Y
3.1
Industry
2.5
Forward
1.6
More Details
2.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.5
vs History
95
vs Industry
56
Median 3Y
3.2
Median 5Y
3.7
Industry
5.1
More Details
8.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
8.5
vs History
96
vs Industry
27
Median 3Y
13.1
Median 5Y
25.1
Industry
12
Forward
7.8
More Details
62.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
62.8
vs History
39
vs Industry
1
Median 3Y
-32.4
Median 5Y
49.4
Industry
17.1
Forward
20.4
More Details
16.1
EV/OCF
EV/OCF
Enterprise Value to OCF
16.1
vs History
49
vs Industry
Median 3Y
-32.3
Median 5Y
16.2
Industry
14.7
More Details
37.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
37.3
vs History
7
vs Industry
Median 3Y
-22.6
Median 5Y
-36.9
Industry
18.8
More Details
0.7
EV/IC
EV/IC
Enterprise Value to IC
0.7
vs History
85
vs Industry
67
Median 3Y
0.8
Median 5Y
0.8
Industry
1.8
More Details

Multiples Across Competitors

ATRY Competitors Multiples
Atrys Health SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
ES
Atrys Health SA
MAD:ATRY
201.8m EUR 0.9 -8.2 8.5 62.8
US
CVS Health Corp
NYSE:CVS
98.2B USD 0.2 209.4 13.8 13.8
US
Cigna Corp
NYSE:CI
73.6B USD 0.3 12 7.7 9.8
US
Cigna Group
XMUN:CGN
62.6B EUR 0.3 12 7.7 9.8
DE
Fresenius SE & Co KGaA
XETRA:FRE
27B EUR 1.2 23.6 10.3 15.7
DE
Fresenius Medical Care AG
XMUN:FME
23.6B EUR 1.2 32.9 10.4 22.1
US
Laboratory Corporation of America Holdings
NYSE:LH
21.4B USD 1.6 25 13.6 19
US
Quest Diagnostics Inc
NYSE:DGX
19.8B USD 1.8 20.6 11.4 15.4
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.6B EUR 0.6 16.2 6.4 13.6
US
Guardant Health Inc
NASDAQ:GH
12.5B USD 13.9 -31.3 -33.1 -30.1
US
DaVita Inc
NYSE:DVA
8.5B USD 0.6 11 6.8 9.3

See Also

Summary
ATRY intrinsic value, competitors valuation, and company profile.
DCF Valuation
ATRY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ATRY stock valuation using valuation multiples.
Wall Street Estimates
ATRY price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ATRY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 303,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.